Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

Menopausal Hormone Therapy May Reduce Carpal Tunnel Syndrome Risk

Menopausal Hormone Therapy May Reduce Carpal Tunnel Syndrome Risk

By

To investigate the association between hormone therapy and carpal tunnel syndrome risk, researchers conducted a secondary analysis of the Women's Health Initiative (WHI) hormone therapy trials.

FDA to Review Estrogen-Free Oral Contraceptive Slinda

FDA to Review Estrogen-Free Oral Contraceptive Slinda

By

Drospirenone is a spironolactone analogue with antimineralocorticoid and antiandrogenic activity.

Hypoglycemia Following Antifungal Treatment in Patient With Type 1 Diabetes

Hypoglycemia Following Antifungal Treatment in Patient With Type 1 Diabetes

By

"This is the first report of decreased insulin requirements in a patient with [T1D] correlating with micafungin administration," noted the authors.

Another Antihypertensive Recalled Due to Potentially Carcinogenic Impurity

Another Antihypertensive Recalled Due to Potentially Carcinogenic Impurity

By

The impurity was identified following laboratory testing conducted by the Food and Drug Administration (FDA); this is the first non-valsartan product that the Agency has found to contain NDEA.

Empagliflozin Treatment Positively Impacts Life Expectancy in T2D With CVD

Empagliflozin Treatment Positively Impacts Life Expectancy in T2D With CVD

By

For this analysis, the authors used follow-up data from all 7020 patients included in the EMPA-REG OUTCOME trial to estimate the effect of empagliflozin on all-cause mortality vs placebo over the duration of a patient's lifetime.

More Articles by Diana Ernst, RPh

Sign Up for Free e-Newsletters



CME Focus